|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - KEMPHARM INC (KMPH)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-10-11 Purchase |
2018-10-15 4:28 pm |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP |
3,000 | $2.525 | $7,575 | 3,000 (Direct) |
View |
| 2018-10-12 Purchase |
2018-10-12 4:35 pm |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
5,000 | $2.553 | $12,764 | 1,703,117 (Indirect Direct) |
View |
| 2018-10-10 Purchase |
2018-10-12 4:12 pm |
KEMPHARM INC | KMPH | Johnson Gordon K Chief Business Officer |
4,000 | $2.614 | $10,457 | 10,000 (Direct) |
View |
| 2018-10-11 Purchase |
2018-10-11 6:52 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO |
650 | $2.541 | $1,652 | 2,750 (Direct) |
View |
| 2018-10-05 Purchase |
2018-10-09 4:01 pm |
KEMPHARM INC | KMPH | Delaware Street Capital Master Fund L.P. DSC Advisors L.P. DSC Managers L.L.C. DSC Advisors L.L.C. BLUHM ANDREW G 10% Owner |
2,000,000 | $3 | $6,000,000 | 4,095,914 (Direct) |
View |
| 2018-07-30 Purchase |
2018-08-01 4:05 pm |
KEMPHARM INC | KMPH | Delaware Street Capital Master Fund L.P. DSC Advisors L.P. DSC Managers L.L.C. DSC Advisors L.L.C. BLUHM ANDREW G 10% Owner |
304,283 | $4 | $1,217,132 | 2,095,914 (Direct) |
View |
| 2018-05-31 Purchase |
2018-06-01 4:14 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO |
525 | $6.1 | $3,202 | 2,100 (Direct) |
View |
| 2018-05-15 Purchase |
2018-05-17 9:18 pm |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
7,900 | $6.446 | $50,921 | 35,500 (Direct Indirect) |
View |
| 2017-11-27 Purchase |
2017-11-29 4:24 pm |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
7,500 | $3.79 | $28,423 | 32,500 (Direct Indirect) |
View |
| 2017-09-25 Purchase |
2017-09-25 4:33 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO |
300 | $3.775 | $1,133 | 1,575 (Direct) |
View |
| 2017-09-13 Purchase |
2017-09-15 1:30 pm |
KEMPHARM INC | KMPH | Delaware Street Capital Master Fund L.P. DSC Advisors L.P. DSC Managers L.L.C. DSC Advisors L.L.C. BLUHM ANDREW G 10% Owner |
325,888 | $3.274 | $1,066,827 | 1,791,631 (Direct) |
View |
| 2017-08-24 Purchase |
2017-08-25 4:32 pm |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
5,000 | $2.576 | $12,882 | 25,000 (Direct) |
View |
| 2017-08-24 Purchase |
2017-08-25 4:31 pm |
KEMPHARM INC | KMPH | Johnson Gordon K Chief Business Officer |
4,000 | $2.601 | $10,404 | 6,000 (Direct) |
View |
| 2017-06-20 Purchase |
2017-06-21 09:06 am |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
8,000 | $3.449 | $27,592 | 1,647,806 (Indirect Direct) |
View |
| 2017-06-19 Purchase |
2017-06-21 08:57 am |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO |
275 | $3.3 | $907 | 1,275 (Direct) |
View |
| 2017-05-25 Purchase |
2017-05-26 4:05 pm |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
2,500 | $4.109 | $10,274 | 20,000 (Direct) |
View |
| 2017-03-29 Purchase |
2017-03-31 4:24 pm |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
2,500 | $4.481 | $11,202 | 17,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-18 Option Award |
2019-02-20 4:26 pm |
N/A 2029-02-17 |
KEMPHARM INC | KMPH | Johnson Gordon K Chief Business Officer |
60,000 | $2.29 | 60,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 7:29 pm |
N/A 2029-02-05 |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
420,000 | $2.66 | 420,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 7:29 pm |
N/A 2029-02-05 |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
60,000 | $2.66 | 420,000 (Indirect) |
View |
| 2019-02-06 Option Award |
2019-02-08 7:28 pm |
N/A 2029-02-05 |
KEMPHARM INC | KMPH | Johnson Gordon K Chief Business Officer |
100,000 | $2.66 | 100,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 7:28 pm |
N/A 2029-02-05 |
KEMPHARM INC | KMPH | Guenther Sven VP |
160,000 | $2.66 | 160,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 5:36 pm |
N/A 2029-02-05 |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP |
60,000 | $2.66 | 60,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 5:36 pm |
N/A 2029-02-05 |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO |
160,000 | $2.66 | 160,000 (Direct) |
View |
| 2018-10-12 Gift |
2018-10-12 4:35 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
32,172 | $0 | 1,703,117 (Direct) |
View |
| 2018-10-12 Gift |
2018-10-12 4:35 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
18,139 | $0 | 1,703,117 (Direct) |
View |
| 2018-10-12 Gift |
2018-10-12 4:35 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
32,172 | $0 | 1,703,117 (Indirect) |
View |
| 2018-10-12 Gift |
2018-10-12 4:35 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
18,139 | $0 | 1,703,117 (Indirect) |
View |
| 2018-05-22 Option Award |
2018-05-24 4:06 pm |
N/A 2028-05-21 |
KEMPHARM INC | KMPH | Saluri Joseph Director |
15,000 | $6.1 | 15,000 (Direct) |
View |
| 2018-05-22 Option Award |
2018-05-24 4:06 pm |
N/A 2028-05-21 |
KEMPHARM INC | KMPH | Tierney David S Director |
15,000 | $6.1 | 15,000 (Direct) |
View |
| 2018-05-22 Option Award |
2018-05-24 4:05 pm |
N/A 2028-05-21 |
KEMPHARM INC | KMPH | Thompson Danny L Director |
15,000 | $6.1 | 15,000 (Direct) |
View |
| 2018-05-22 Option Award |
2018-05-24 4:04 pm |
N/A 2028-05-21 |
KEMPHARM INC | KMPH | Plooster Matthew R Director |
15,000 | $6.1 | 15,000 (Direct) |
View |
| 2018-05-22 Option Award |
2018-05-24 4:04 pm |
N/A 2028-05-21 |
KEMPHARM INC | KMPH | Pascoe Richard W Director |
15,000 | $6.1 | 15,000 (Direct) |
View |
| 2018-03-23 Exercise |
2018-03-27 5:22 pm |
N/A N/A |
KEMPHARM INC | KMPH | Thompson Danny L Director |
3,333 | $4.65 | 91,687 (Direct) |
View |
| 2018-03-23 Tax Withholding |
2018-03-27 5:22 pm |
N/A N/A |
KEMPHARM INC | KMPH | Thompson Danny L Director |
2,026 | $7.65 | 91,687 (Direct) |
View |
| 2018-03-23 Exercise |
2018-03-27 5:22 pm |
N/A 2018-03-30 |
KEMPHARM INC | KMPH | Thompson Danny L Director |
3,333 | $4.65 | 91,687 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:57 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP |
30,000 | $5.5 | 30,000 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:56 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Guenther Sven VP |
75,000 | $5.5 | 75,000 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:56 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
75,000 | $5.5 | 75,000 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:56 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Johnson Gordon K Chief Business Officer |
75,000 | $5.5 | 75,000 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:56 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO |
75,000 | $5.5 | 75,000 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:56 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
225,000 | $5.5 | 225,000 (Direct) |
View |
| 2018-01-25 Option Award |
2018-01-29 6:56 pm |
N/A 2028-01-24 |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
30,000 | $5.5 | 225,000 (Indirect) |
View |
| 2017-11-27 Gift |
2017-11-29 4:24 pm |
N/A N/A |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
2,500 | $0 | 32,500 (Direct) |
View |
| 2017-11-27 Gift |
2017-11-29 4:24 pm |
N/A N/A |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
1,250 | $0 | 32,500 (Indirect) |
View |
| 2017-11-27 Gift |
2017-11-29 4:24 pm |
N/A N/A |
KEMPHARM INC | KMPH | Cohen Daniel L VP |
1,250 | $0 | 32,500 (Indirect) |
View |
| 2017-06-20 Gift |
2017-06-21 09:06 am |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
32,269 | $0 | 1,647,806 (Direct) |
View |
| 2017-06-20 Gift |
2017-06-21 09:06 am |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
18,194 | $0 | 1,647,806 (Direct) |
View |
| 2017-06-20 Gift |
2017-06-21 09:06 am |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
32,269 | $0 | 1,647,806 (Indirect) |
View |
| 2017-06-20 Gift |
2017-06-21 09:06 am |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Travis C CEO, 10% Owner |
18,194 | $0 | 1,647,806 (Indirect) |
View |
| 2017-05-23 Option Award |
2017-05-24 7:52 pm |
N/A 2027-05-22 |
KEMPHARM INC | KMPH | Tierney David S Director |
10,000 | $3.95 | 10,000 (Direct) |
View |
| 2017-05-23 Option Award |
2017-05-24 5:32 pm |
N/A 2027-05-22 |
KEMPHARM INC | KMPH | Thompson Danny L Director |
10,000 | $3.95 | 10,000 (Direct) |
View |
| 2017-05-23 Option Award |
2017-05-24 5:30 pm |
N/A 2027-05-22 |
KEMPHARM INC | KMPH | Saluri Joseph Director |
10,000 | $3.95 | 10,000 (Direct) |
View |
| 2017-05-23 Option Award |
2017-05-24 5:30 pm |
N/A 2027-05-22 |
KEMPHARM INC | KMPH | Plooster Matthew R Director |
10,000 | $3.95 | 10,000 (Direct) |
View |
| 2017-05-23 Option Award |
2017-05-24 5:26 pm |
N/A 2027-05-22 |
KEMPHARM INC | KMPH | Pascoe Richard W Director |
10,000 | $3.95 | 10,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 25 Aug 2019 01:57:31 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |